
Attacks by NHS trust's patients ‘do not surprise us', say Nottingham families
The mother of a student killed in the Nottingham attacks has said the victims' families stand united with anyone affected by stabbings carried out by those under the care of a 'woefully inadequate' mental health trust.
Emma Webber, mother of Barnaby Webber, said the failings of Nottinghamshire Healthcare NHS Trust 'continue to concern but sadly not surprise us' following the news that two men with paranoid schizophrenia, treated by the trust, stabbed members of the public in separate incidents weeks before the attacks.
Josef Easom-Cooper and Junior Dietlin attacked six men in the county in 2023.
Dr Susan Elcock, deputy chief executive and executive medical director at the trust, apologised 'for any aspect of our care which was not of the high standard our patients, their families and our communities deserve'.
Another of the trust's patients, Valdo Calocane, went on to kill students Barnaby and Grace O'Malley-Kumar, both 19, and caretaker Ian Coates, 65, before attempting to kill three other people in the city in June 2023.
A report into Calocane's care said he was not forced to have long-lasting anti-psychotic medication because he did not like needles.
On behalf of the Nottingham families, Ms Webber told the PA news agency: 'Unless we expose those who are failing individually then nothing will ever change.'
She said: 'The findings in the latest revelation about the Nottinghamshire mental health trust and its failings continue to concern but sadly not surprise us.
'As has been proven, it was a woefully inadequate, failing service.
'The statutory inquiry will provide our family with the opportunity to do the deeper dive and find out much more detail than any of the half-baked investigations that have taken place so far.
'What we find personally insulting is this continued 'unreserved apology and lessons will be learned' – they are not. They never have been.
'Unless we expose those who are failing individually then nothing will ever change.
'We completely stand united with anyone affected by any of these crimes, and in Barney, Grace and Ian's name, we will hold those to account who failed in any agency, and we will make sure that there is lasting change, not unreserved apologies and dusty reports on shelves.'
In April 2023, Easom-Cooper stabbed a church-goer outside an Easter service and was sentenced to a hospital order in December of the same year.
His mother, Shelly Easom, told the BBC he was sectioned in 2022 for three months and was discharged despite her telling the trust that he 'was not OK when he was released'.
She told the broadcaster the attack could have been prevented if his condition had been taken more seriously.
Dietlin stabbed five strangers in Nottingham and Mansfield nine weeks before the attack by Easom-Cooper and he also received a hospital order.
Former police officer Keith Grafton, who was one of Dietlin's victims, told the BBC he was 'disappointed' his attacker had not received a prison sentence.
The broadcaster said a report showed Dietlin had been involved with violent incidents with staff at Highbury Hospital in June 2022 and following his release, he took his medication 'very irregularly'.
The BBC reported the day after his first attack on February 8 2023, he was visited by a staff member at the trust for a medication drop, but when community staff visited they found no signs of psychosis.
Dietlin stabbed four more people between February 11 and 12.
The trust said learning was identified in both cases – including capacity and risk assessment, liaison with police, medication drop-offs and follow-up and the role of families in working with patients who were harder to engage with.
Dr Elcock said: 'Firstly, I apologise to those impacted by these incidents and for any aspect of our care which was not of the high standard our patients, their families and our communities deserve.
'Whilst we are unable to comment on individual cases due to patient confidentiality, I want to assure people that following any serious incident there is a robust review process which includes an initial management review to ensure any immediate learning and action takes place.
'This is then followed by a full investigation and a clear quality improvement plan detailing any learning and subsequent actions required.
'We have also implemented the new national patient safety incident response framework (PSIRF) which further strengthens this review and learning process.
'We know that it is really important for patients and families to be fully involved and I am confident our approach now ensures this happens, and that issues are addressed swiftly and transparently with patients involved in every aspect of their care.
'Above all, we remain fully committed to ensuring all our patients and their families receive the care they deserve, and our communities feel safe.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Sun
36 minutes ago
- The Sun
The 4 signs of skin cancer beyond moles as Atomic Kitten's Natasha Hamilton reveals diagnosis after ‘itch on her back'
ATOMIC Kitten's Natasha Hamilton opened up about her skin cancer battle, revealing she was diagnosed with the disease after getting a persistent itchy spot on her back. In an emotional Good Morning Britain interview, the singer, 42, revealed she'd had basal cell carcinoma (BCC). 9 9 BCC is the most common skin cancer type in the UK. It begins in the basal cells — a type of cell within the skin that produces new skin cells as old ones die off - and is more likely to develop on skin regularly exposed to the sun, like the face, head or neck. The cancer often tends to appear as a pearly lump, but it can also develop as a scar-like patch on the skin or rough, scaly growths. Natasha initially mistook the diseased patch of skin as a mosquito bite. She told her hosts Kate Garraway and Rob Rinder that she developed an itch after catching a bit too much sun while on holiday in Majorca. Natasha said: "So I had been on holiday, I wasn't actually in the sun a lot, my baby was only about five months old and I was breastfeeding. "One afternoon I had her on my lap, my back was in the sun and I burnt. "I don't know if it was later that day or the next day, I had an itchy spot on my back. "I felt it, I went "oh mosquito bite". 'It wasn't until four weeks later when I was at home and it was itching I was like 'hang on a minute, that seems a bit long for a mosquito bite'. 'I asked my husband to have look and he went "oh that's not a bite," he took a picture. Natasha revealed: "Originally it had just been a dark freckle that I'd had on my back for many years. "It wasn't even raised, it wasn't a mole, it was just a freckle." The star sought specialist help and was diagnosed with BCC. 9 9 9 She was able to have the cancerous skin removed and is now living cancer-free. But she revealed: "Now I have to be really vigilant, I have to check my skin all the time. "Since then I've had a few things appear where I've had to go back to the dermatologist, they're on the 'watch list'. "This is probably something I am going to have to keep an eye for the rest of my life," Natasha said. The 4 signs of BCC When you think of signs of skin cancer, a mole probably comes to mind. This is usually the case with melanoma, the deadliest form of the disease. But non-melanoma skin cancer - which includes BCC - can manifest in other more subtle ways. According to Macmillan Cancer Support, a BCC might have some of these features: A smooth, firm lump that may be pearly, pink, red, brown or black – on black or brown skin, it is more likely to be pearly, brown or black A lump that is sunken in the middle like a crater A flat patch of scaly, crusty or irritated skin A scar-like area of pale, shiny skin This type of skin cancer tends to be painless but it can cause itchiness or bleeding. 9 9 9 Over time, a BCC may develop into an open sore that does not heal. Any part of your skin can be affected, but it's most common in areas exposed to the sun, such as the: Head, face and ears Neck and shoulders Back Hands Lower legs BCCs mainly people with fair skin, but those with other skin types may also be at risk, according to the British Skin Foundation. Those with the highest risk of developing a basal cell carcinoma are: People with pale skin who burn easily and rarely tan Those who have had a lot of exposure to the sun, such as people with outdoor hobbies or outdoor workers, and people who have lived in sunny climates People who have used sun beds or have regularly sunbathed. People who have previously had a basal cell carcinoma Almost all cases of BCC can be cured and it's almost never a danger to life, according to the charity. However, if a BCC is not treated early, it may get larger and may be more likely to come back. Treatment can include surgically removing the affected area of skin. There are two main types of skin cancer - non melanoma skin cancer and melanoma skin cancer. Non melanoma skin cancer includes: Basal cell skin cancer - this is also called basal cell carcinoma (BCC) Squamous cell skin cancer - this is also called squamous cell carcinoma (SCC) Some other rare types Non melanoma skin cancers tend to develop most often on skin that's exposed to the sun. There is a high cure rate for these cancers. Most people only have minor surgery and don't need further treatment. Melanoma skin cancer is when abnormal cells in the skin start to grow and divide in an uncontrolled way. It starts in skin cells called melanocytes. These cells are in the deep layer of the epidermis. Around 17,500 people are diagnosed with melanoma skin cancer in the UK each year. The number of people diagnosed has increased over the last few decades. Melanoma skin cancer is the fifth most common cancer in the UK.


Daily Mail
39 minutes ago
- Daily Mail
Statins slash death from terrifying 'hidden' condition that kills 48,000 a year by 40 per cent, new study finds
Taking statins can improve the chances of surviving 'hidden' killer sepsis by 40 per cent, a major new trial has found. Sepsis can occur when the body's immune system—which usually helps to fight infection—overreacts to an infection and attacks its own organs. It is notoriously difficult to spot as the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins are cholesterol-busting drugs that prevent heart attacks and strokes and are taken by around 5million adults in the UK. Experts have said they also have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The latest study compared survival rates of sepsis patients who were given statins, and those who didn't, during a hospital stay. It found the cholesterol-busting pills reduced risk of death for those with the life-threatening condition by 39 per cent. In the intensive care unit, 14.3 per cent of 6,000 sepsis patients who were given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. It also helped survival rates for those no longer in a critical condition—11 per cent of sepsis patients in this group given statins died compared to 19 per cent who were not. Meanwhile, those who were prescribed statins had a slightly longer stay in hospital than those who didn't—an average of 10 days compared to eight. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' The research team have called for larger trials to confirm their findings—which was based on a data from thousands of patients at a hospital in Israel over a decade. In response UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, added: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' The study is the latest to find statins, one of the most commonly prescribed medications in the UK, could have other health benefits beyond controlling cholesterol. Earlier this year researchers found taking the pills, which cost mere pennies a tablet, could also slash dementia risk—even in patients who don't have high cholesterol. Sepsis, known as the 'silent killer', strikes with frightening speed and, for every hour of delay, a patient's chance of dying increases 8 per cent. If caught early enough, it can be easily treated with intravenous antibiotics and fluids, but these must be given as soon as sepsis is suspected. The early symptoms of sepsis can be easily confused with more mild conditions, meaning it can be difficult to diagnose. A high temperature, chills and shivering, a fast heartbeat and rapid breathing are also indicators. A patient can rapidly deteriorate if sepsis is missed early on, so quick diagnosis and treatment is vital–yet this rarely happens. In the early stages, sepsis can be mistaken for a chest infection, flu or upset stomach. It is most common and dangerous in older adults, pregnant women, children younger than one, people with chronic conditions or those who have weakened immune systems. The six potential signs of the deadly condition can be identified by the acronym 'SEPSIS'. Slurred speech or confusion, Extreme shivering or muscle pain, Passing no urine in a day, Severe breathlessness, and Skin that's mottled or discoloured. Anyone who develops any of these symptoms should seek medical help urgently—and ask doctors: 'Could this be sepsis?'


Daily Mail
an hour ago
- Daily Mail
9 of the best new anti-ageing face sunscreens for all skin types, tested by beauty experts
Most of us are aware we should be applying sunscreen year-round, even when it's grey and cloudy outside. It's well known that an SPF can block sunburns and prevent skin cancer, but many dermatologists agree that it's also the best skincare product for slowing signs of ageing, such as hyperpigmentation and wrinkles. Which is exactly why we should all get into the habit of wearing sunscreen every day (if you aren't already doing so). The key to consistency is finding a face sunscreen that you love. To make that search a little easier for you, we at YOU magazine have been testing a bunch of new SPFs (some even on holiday). So, scroll down for nine of the very best face sunscreens you can buy for summer, reviewed by the YOU team. £25 Shop Who tested it? Rosie Green, beauty editor Skin type? Rosacea prone Age? 51 Why we love it? I've finally found sunscreen nirvana and it comes in the form of La Roche-Posay Anthelios UVAir SPF 50+. Why is it so good? Well, it feels weightless on the skin. Sinks in quickly. Leaves no white cast. It smells heavenly (fresh, but not overly scented). And it doesn't make my skin feel greasy or trigger my rosacea, just lightly hydrates. It feels like a pleasure not a chore. Frankly, it's a skincare miracle. Laneige Hydro UV Defense EX SPF 50 £26 Shop Who tested it? Charlotte Vossen, deputy digital editor Skin type? Sensitive Age? 29 Why we love it? There are four things I look for in a face SPF; it needs to be fragrance-free, hydrating, offer broad spectrum protection and have an SPF rating of 50 or higher, and deliver a dewy finish without looking greasy. I had high hopes for this as I'm obsessed with Korean sunscreens, and while it does deliver on three of the four – it's lightweight yet hydrating, offers SPF 50+, and gives the skin a fresh glow – it does contain fragrance. £31 Shop Who tested it? Jessica Carroll, junior style editor Skin type? Combination Age? 28 Why we love it? I loved trying out the Glow Recipe Watermelon Glow SPF 30. It's a really light consistency which is great as it meant it absorbed really quickly and didn't require much rubbing for the white cream to disappear into my skin. I like to wear makeup over my SPF and this didn't make my makeup pile or slip off. It also has a really nice watermelon smell which might put some people off but I loved it. The only thing I would change would be to make it a SPF 50 as I like as much protection as possible with my SPF. £20 Shop Who tested it? Lila Flint-Roberts, senior bookings editor Skin type? Sensitive Age? 30 Why we love it? It's very lightweight, absorbs quickly, doesn't leave a white cast and is actually quite glowy, like a primer. It's not scented but has a slight tang owing to the vitamin C. I reapplied every hour while I was on holiday in Tuscany and it built quite nicely – didn't go too claggy or flakey! At £20 it's also affordable, so I'd definitely repurchase. The Organic Pharmacy Daily Mineral SPF 30 UV Protection £45 Shop Who tested it? Marion Jones, sub editor Skin type? Sensitive and dry Age? 62 Why we love it? Its holiday feel isn't quite what I want in the city - although the scent disappears as soon as it's smoothed on – and application is serviceable rather than luxuriant. But then, heaven, it has an invisible matt finish and, though just SPF 30, its mineral filters and botanicals prevent the usual pink hue my pale skin develops at the first hint of sun. I always prefer eco products and this one is impressive. Rituals The Ritual of Namaste Daily Moisturiser SPF 50 £40 Shop Who tested it? Sophie Hines, digital and lifestyle editor Skin type? Normal Age? 37 Why we love it? I didn't actually realise that Rituals do SPFs – I associate the brand more with bath and body products – but I really liked this product. It's great to see such a high factor SPF combined with a moisturiser, as many of the moisturisers I've tried before are closer to SPF 15 than 50. It feels light but nourishing on the skin, and goes well under make-up without making my face all shiny (a personal hate!). I think it would be hard for this to tear me away from La Roche-Posay SPF, especially with a £40 price tag, but I certainly think it's a good all-rounder. Supergoop! Unseen Sunscreen SPF 30 £32 Shop Who tested it? Scarlett Dargan, features writer Skin type? Combination Age? 26 Why we love it? I was initially a bit worried because I often find new products (in particular, new SPFs) clog up my pores and cause me to break out. But I honestly cannot recommend this product enough. It's so velvety to apply, soaks in instantly, feels weightless when on and layers perfectly under make-up. The grippy primer claims on the packet are definitely true! I struggle with an oily T-zone when I'm on holiday but this didn't cause any greasiness, made my pores look smoother, and meant I didn't burn, at all, during my trip to Turkey (and I'm ginger, so that's impressive). I'll definitely be using this from now on. £77 Shop Who tested it? Natasha Tomalin-Hall, creative director Skin type? Sensitive Age? 37 Why we love it? Having sensitive skin means I have to be really careful with SPF as it can quickly cause upset and breakouts. This formula was really gentle and caused no stress to my skin whatsoever. The smell was neutral and the texture quite light. On application the product took a little time to absorb and went on quite white initially, but once absorbed it wasn't greasy and almost totally disappeared. It cost a little more than I would usually spend on SPF but worth it for the feel and efficacy. I would buy it again. £50 Shop Who tested it? Sophie Dearden-Howell, fashion director Skin type? Combination Age? 34 Why we love it? This SPF serum has a shimmer and tint that looks quite dark when you first apply it, but as you rub it in, it adds a healthy glow. It's on the thicker side, so I'd wait a minute and let it absorb in the skin before applying make-up, but it does make for a really gorgeous base. Plus, I love the packaging – it's super easy to use and you don't have to worry about it exploding in your wash bag.